$9.72
+0.73%AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
Declining FCF warrants attention. Investigate whether due to temporary factors or fundamental deterioration.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Capital-intensive growth: Heavy reinvestment limits current cash available but may drive future returns. Assess whether CapEx supports compelling growth opportunities with adequate ROI.
AHCO โข NASDAQ
| AdaptHealth Corp. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||
-66M | 94.8M | -678.9M | 73.1M | 158.2M | -194.1M | 12.2M | 2.1M | -690.0 | -4.2M | |
381.9M | 365.3M | 420.6M | 351.2M | 258.1M | 82.4M | 11.3M | 50.6M | 27.8M | 26.6M | |
47.2M | 32M | -62.6M | 18M | 22.4M | -21.1M | 895.3K | -2.9M | 0.0 | 0.0 | |
21.9M | 14.9M | 22.5M | 22.4M | 25.3M | 18.7M | 11.1M | 884K | 48.8K | 48.8K | |
150.3M | 60.9M | 804.2M | 17.1M | -34.9M | 232.8M | 43.1M | 65.9M | 12M | 17.3M | |
(0.0) | (14.1M) | (14.8M) | (14.9M) | (14.8M) | (7.5M) | (1.3M) | (0.0) | (0.0) | (0.0) | |
66.6M | -26.1M | -25.1M | -108M | -153.3M | 76.9M | -18.2M | 429.3K | 690.0 | -9.7M | |
601.8M | 541.8M | 480.7M | 373.9M | 275.7M | 195.6M | 60.4M | 68.4M | 45.9M | 29.9M | |
INVESTING ACTIVITIES | ||||||||||
-382.4M | -306.1M | -337.5M | -391.4M | -203.3M | -39.8M | -21.3M | -9.9M | -6.9M | -2.5M | |
-42.4M | -9.5M | -19.7M | -19M | -1.6B | -769.3M | (569K) | -86.3M | -8.5M | -1.3M | |
(0.0) | (0.0) | -128K | -731K | -1.1M | -8.7M | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 2M | 0.0 | 0.0 | 0.0 | 0.0 | |
121.6M | 5.3M | 0.0 | 0.0 | 0.0 | 0.0 | 20.4M | -238.9M | 280.5K | 1.1M | |
-303.2M | -310.3M | -357.3M | -411.2M | -1.8B | -815.7M | -386K | -248.9M | -15.1M | -2.7M | |
FINANCING ACTIVITIES | ||||||||||
1.2M | 0.0 | -29.3M | -14M | 278.9M | 323.3M | 101.3M | 250M | 0.0 | -800K | |
-268.5M | -179.9M | -51.8M | -36.2M | 1.4B | 354.7M | 205.7M | -174.2K | -29.7M | -25.7M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -250M | (0.0) | (0.0) | (0.0) | |
(0.0) | (0.0) | -29.3M | -14M | (0.0) | -44.3M | -23.7M | (0.0) | (25K) | -800K | |
-34.9M | -19.1M | -11.5M | -15.9M | -75.7M | -34.9M | -70.8M | 1.5M | -574K | -1.1M | |
-302.2M | -198.9M | -92.5M | -66.1M | 1.6B | 643.2M | -13.9M | 251.3M | 119.8K | -27.6M | |
CASH FLOW SUMMARY | ||||||||||
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -47M | -70.1M | 0.0 | 0.0 | |
-3.6M | 32.6M | 30.9M | -103.4M | 49.7M | 23.1M | -875K | 827.3K | -3.6M | -320.4K | |
109.7M | 77.1M | 46.3M | 149.6M | 100M | 76.9M | 10.6M | 119.8K | 3.7M | 4M | |
106.1M | 109.7M | 77.1M | 46.3M | 149.6M | 100M | 9.8M | 947.1K | 119.8K | 3.7M | |
219.4M | 235.8M | 143.2M | -17.6M | 72.4M | 155.9M | 39.1M | 58.5M | 39.1M | 27.5M |
AHCO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K/A 8-K/A 2026 (Amended) N/A | June 02, 2026 | May 04, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 18, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 10, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 24, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 24, 2026 | February 24, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 04, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 04, 2025 | November 04, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 05, 2025 | June 30, 2025 | 2025 |
Continue your AHCO research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.